Section one: Contracting authority
one.1) Name and addresses
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
10 South Colonnade
London
E14 4PU
Contact
Major Programmes, UKHSA
majorprogrammespin@ukhsa.gov.uk
Country
United Kingdom
Region code
UKI42 - Tower Hamlets
Internet address(es)
Main address
https://www.gov.uk/government/organisations/uk-health-security-agency
Buyer's address
https://www.gov.uk/government/organisations/uk-health-security-agency
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Centralised Adult Flu Procurement
two.1.2) Main CPV code
- 33651600 - Vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
Following the publication of the NHS Vaccination Strategy (2023), NHSE, UKHSA and DHSC are exploring whether centralising the procurement and/or supply of adult flu vaccine could deliver a more efficient and effective outcome and provide improvements on the current models.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
UKHSA, as the potential Contracting Authority, are leading the pre-market engagement activity with the purpose to:
• Gain a better understanding of the ‘as-is’ adult NHS flu programme from the perspective of vaccine manufacturers and wholesalers
• Understand what impact centralising the procurement and/or supply of adult flu vaccine would potentially have on the market including current capability and capacity; options under consideration include
o Procuring Adult Flu Vaccines using a Centralised Framework Contract
o UKHSA Procuring Adult Flu Vaccines and maintaining existing supply and distribution methods
o UKHSA Procuring Adult Flu Vaccines and ingesting supply centrally for distribution
o Maintaining the status quo
• Explore any potential barriers, opportunities, benefits or risks there may be with a central procurement and/or supply approach.
• Have an open dialogue with the market to ensure a full understanding of the future landscape.
The market engagement will take the form of a questionnaire available via our e-procurement system, which you will be asked to complete and return. Once returned, you may be invited for a 1:1 meeting with the project team to discuss your answers and provide clarification. It is anticipated that these meetings will take place during November/December 2024.
Who would we like to hear from?
We are keen to engage with those suppliers who already have a licenced adult flu vaccine and/or have experience of the UK adult flu market, who have an adult flu vaccine in development, or who may have an adult flu vaccine in their future product development pipeline, and with medical logistics providers both wholesale and distribution.
How to participate?
The opportunity will be available on the Atamis eTendering system, access here: https://atamis-1928.my.site.com/s/Welcome . If you do not already have an account you can easily register for one via the same link. You will then be able to search for this opportunity and access the questionnaire and any other related documents. Please note that all correspondence must be conducted through the Atamis system. The response window will close at 5pm on Sunday 17th November 2024.
two.3) Estimated date of publication of contract notice
28 October 2024
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes